Search Results 571-580 of 15230 for TNF
This phase I trial studies the side effects and the best dose of everolimus when given together with brentuximab vedotin in treating patients with Hodgkin ...
AR-42 is a small molecule which crosses the blood brain barrier (BBB) in rodents, but the investigators are not certain yet if it will penetrate human ...
Mayo Clinic researchers study genetics, causes and new treatments for people with neurofibromatosis type 1. Research is conducted by Mayo Clinic researchers in ...
This study will include some patients receiving the hormone therapy and some patients who are not, so we can better understand whether patients getting the ...
Study K36-MCRPC-001 is the first in human clinical trial testing KTX-2001 alone and with darolutamide in men with metastatic castration-resistant prostate ...
About this study. This first-in-human clinical trial is a Phase 1/1b, open-label, sequential-group, dose-escalation and cohort expansion study evaluating ...
The purpose of the study is to learn more about inflammatory diseases of the central nervous system (CNS) by collecting patient information, blood sample (which ...
The phase 1 primary objectives of this study are to assess the safety profile, characterize pharmacokinetics (PK) and determine the dosing schedule, maximum ...
Find out how healthcare teams use innovative treatments such as transoral robotic surgery and proton therapy to treat this type of throat cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.